ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIRO..CY..TRBGCZEEHUPLSK....IS..............................*JJDIM360 Ver 1.28 (29 Oct 2014) - 2999001/01981343CORRECTED EUROPEAN PATENT SPECIFICATIONB8B120150624W173deBibliographieenBibliographyfrBibliographieEP07716706.2200701172008081120140213enenen759027 P20060117US2015062420152620081022200843201505132015202014120220150624201526A01N 43/78 20060101AFI20080828BHEP A61K 31/425 20060101ALI20080828BHEP deBEHANDLUNG VON ENTZÜNDUNGSERKRANKUNGEN MIT TRIAZOLVERBINDUNGENenTREATMENT OF INFLAMMATORY DISORDERS WITH TRIAZOLE COMPOUNDSfrTRAITEMENT DE TROUBLES INFLAMMATOIRES AVEC DES COMPOSES DE TRIAZOLEWO-A1-96/30350WO-A1-2005/019216WO-A1-2005/044287WO-A2-2006/031929US-A- 6 124 330US-B1- 6 787 556N. E. MEALY, M. BAYES: "Annual update 2004/2005 - Treatment of dermatological disorders" DRUGS OF THE FUTURE, vol. 30, no. 8, 2005, pages 815-869, XP00260592920101117COOLS, MarinaDalialaan 7B-2470 RetieBEBORGERS, MarcelCipalstraat 3B-2440 GeelBEStiefel Laboratories, Inc.101521113RXT/FP6574990Corporation Service Company 2711 Centreville Road Suite 400Wilmington, DE 19808USReeves, Julie Frances101274354GlaxoSmithKline Global Patents (CN925.1) 980 Great West RoadBrentford, Middlesex TW8 9GSGBATBEBGCHCYCZDEDKEEESFIFRGBGRHUIEISITLILTLULVMCNLPLPTROSESISKTRUS200700120220070117enWO200708454220070726200730